Literature DB >> 9834354

The role of laparoscopy in the preoperative staging of pancreatic carcinoma.

B Rumstadt1, M Schwab, K Schuster, E Hagmüller, M Trede.   

Abstract

Between January 1990 and December 1995, a total of 398 patients underwent laparotomy for pancreatic or periampullary carcinoma at the Surgical Clinic of Mannheim. The tumor was located in the pancreatic head in 290 patients (72.9%), in the body of the pancreas in 42 patients (10.6%), and in the pancreatic tail in 19 patients (4.7%). Forty-seven patients (11.8%) presented with periampullary carcinoma. The preoperative diagnostic workup included abdominal ultrasound, CT scan, endoscopic retrograde cholangiopancreatography, and angiography. One hundred seventy-two patients (43.2%) underwent a tumor resection, 150 (37.7%) had a palliative bypass operation, and 76 (19.1%) underwent only an exploratory laparotomy. Preoperative diagnosis had predicted unresectability in 66 (87%) of the patients who underwent exploratory laparotomy. In 76 patients the intraoperative findings showed an unresectable tumor, which was located in the head of the pancreas in 54 cases (71%), in the body of the pancreas in 17 (22.4%), in the tail region in four (5.3%), and in the periampullary region in one (1.3%). Local signs of unresectability were found in 47 patients (62%) and peritoneal or hepatic metastases in 29 (28.2%). Given that local inoperability can be reliably assessed only at laparotomy, this leaves just 29 (7%) of 398 patients who did not require palliation and whose signs of unresectability could possibly have been discovered by means of the laparoscopic approach. Laparoscopy (including laparoscopic ultrasound) should be used selectively in patients considered probably unresectable who do not require a palliative procedure immediately before the planned operation.

Entities:  

Mesh:

Year:  1997        PMID: 9834354     DOI: 10.1016/s1091-255x(97)80116-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

2.  The effects of regionalization on cost and outcome for one general high-risk surgical procedure.

Authors:  T A Gordon; G P Burleyson; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

Review 3.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

4.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

5.  Intraoperative ultrasonography in pancreatic cancer.

Authors:  G Serio; C Fugazzola; C Iacono; I A Bergamo Andreis; A Portuese; M Zicari; S Dall'Oglio; M Trivisone; A Dagradi
Journal:  Int J Pancreatol       Date:  1992-02

6.  The role of selective visceral angiography in the management of pancreatic and periampullary cancer.

Authors:  M Murugiah; J A Windsor; D N Redhead; J S O'Neill; B Suc; O J Garden; D C Carter
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

7.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

8.  Peritoneal metastases in pancreatic carcinoma.

Authors:  C F del Castillo; L Warshaw
Journal:  Hepatogastroenterology       Date:  1993-10

Review 9.  Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting.

Authors:  B Gudjonsson
Journal:  J Am Coll Surg       Date:  1995-12       Impact factor: 6.113

10.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more
  15 in total

Review 1.  Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?

Authors:  Thomas B Brunner
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 2.  [Staging laparoscopy in oncology].

Authors:  H Feussner; F Härtl
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

3.  The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.

Authors:  Saxon Connor; Emma Barron; Stephen J Wigmore; Krishnakumar K Madhavan; Rowan W Parks; O James Garden
Journal:  J Gastrointest Surg       Date:  2005-04       Impact factor: 3.452

4.  Staging laparoscopy for proximal pancreatic cancer in a magnetic resonance imaging-driven practice: what's it worth?

Authors:  Elliot Tapper; Bobby Kalb; Diego R Martin; David Kooby; N Volkan Adsay; Juan M Sarmiento
Journal:  HPB (Oxford)       Date:  2011-08-19       Impact factor: 3.647

Review 5.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

6.  Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?

Authors:  Christopher J Barreiro; Keith D Lillemoe; Leonidas G Koniaris; Taylor A Sohn; Charles J Yeo; JoAnn Coleman; Elliot K Fishman; John L Cameron
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

7.  Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies.

Authors:  V Velanovich; I Wollner; M Ajlouni
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

8.  Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival.

Authors:  John D Allendorf; Margaret Lauerman; Aliye Bill; Mary DiGiorgi; Nicole Goetz; Efsevia Vakiani; Helen Remotti; Beth Schrope; William Sherman; Michael Hall; Robert L Fine; John A Chabot
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

9.  The role of radiation therapy in pancreas cancer.

Authors:  Lisa Hazard
Journal:  Gastrointest Cancer Res       Date:  2009-01

10.  Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.

Authors:  Prithivi Raj; Lileswar Kaman; Rajinder Singh; Divya Dahyia; Anish Bhattacharya; Amanjit Bal
Journal:  Updates Surg       Date:  2013-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.